All In Biotech

Drug Trial Radar · NCT04083976

A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

316

Actual

Start

Nov 20, 2019

Primary completion

Dec 4, 2023

Study completion Feb 28, 2026

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Sep 10, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of erdafitinib in terms of overall response rate (ORR) in adult and pediatric participants with advanced solid tumors with fibroblast growth factor receptor (FGFR) alterations (mutations or gene fusions). It will also evaluate ORR in pediatric participants with advanced solid tumors and FGFR alterations.

Conditions

  • Advanced Solid Tumor

Interventions

  • ErdafitinibDrug

    Participants will receive erdafitinib oral tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Broad Panel and Pediatric Cohorts: Objective Response Rate (ORR) Based on Response Assessment in Neuro-Oncology (RANO) as Assessed by Independent Review Committee (IRC)Time frame: Baseline (Cycle 1 Day 1 [each cycle of 21 days]) up to 4 years
  2. Core Panel Cohort: Objective Response Rate (ORR) Based on Response Assessment in Neuro-Oncology (RANO) as Assessed by Independent Review Committee (IRC)Time frame: Baseline (Cycle 1 Day 1 [each cycle of 21 days]) up to 4 years

Locations

179 sites in 15 countries. Site status is shown where the registry gives one.

  • Arizona Oncology Associates, PC - HOPE

    Tucson, Arizona

  • Rocky Mountain Cancer Centers

    Colorado Springs, Colorado

  • Memorial Cancer Institute

    Hollywood, Florida

  • Cancer Specialists of North Florida

    Jacksonville, Florida

  • Emory University

    Atlanta, Georgia

  • Hawaii Cancer Care

    ‘Aiea, Hawaii

  • Maine Medical Center

    Scarborough, Maine

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Mount Sinai

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Levine Cancer Institute, Carolinas HealthCare System

    Charlotte, North Carolina

  • Oncology Hematology Care

    Cincinnati, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Tennessee Oncology, PLLC

    Chattanooga, Tennessee

  • Tennessee Oncology

    Nashville, Tennessee

  • Texas Oncology Baylor Charles A Sammons Cancer Center

    Dallas, Texas

  • Texas Oncology-Fort Worth Cancer Center

    Fort Worth, Texas

  • MD Anderson

    Houston, Texas

  • Oncology Consultants Texas

    Houston, Texas

  • Texas Oncology Odessa-West Texas Cancer Center

    Odessa, Texas

  • Texas Oncology San Antonio Northeast

    San Antonio, Texas

  • NorthWest Medical Specialties, PLLC

    Tacoma, Washington

  • Aurora Research Institute

    Wauwatosa, Wisconsin

  • Instituto de Investigaciones Metabólicas

    Buenos Aires, Argentina

  • Hospital Aleman

    Buenos Aires, Argentina

  • Centro Oncológico Korben

    Buenos Aires, Argentina

  • Instituto Fleni

    Buenos Aires, Argentina

  • CEMIC Saavedra

    Buenos Aires, Argentina

  • Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica

    Córdoba, Argentina

  • Hospital Italiano de La Plata

    La Plata Lpl Lpl, Argentina

  • Instituto de Investigaciones Clinicas Mar del Plata

    Mar del Plata, Argentina

  • Hospital Privado de Comunidad

    Mar del Plata, Argentina

  • Hospital Universitario Austral

    Pilar, Argentina

  • Sanatorio Britanico de Rosario

    Rosario, Argentina

  • ARS Médica

    San Salvador de Jujuy, Argentina

  • Flinders Centre for Innovation in Cancer

    Adelaide, Australia

Showing 40 of 179 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.